MENU
  • モルミル株式会社
  • 企業理念
  • English
    • 日本語
    • English
Welcome to molmir, the company which delivers a new molecular dynamics detection method
molmir official
  • モルミル株式会社
  • 企業理念
  • English
    • 日本語
    • English
molmir official
  • モルミル株式会社
  • 企業理念
  • English
    • 日本語
    • English
  1. Home
  2. Corporate Mission

Corporate Mission

Cure all diseases and make society healthy

Create a technological innovation by mobilizing scienctific assets

Currently, many diseases in the world are considered incurable. Despite the day-and-night advancements in science and technology working to unravel these mysteries, developing a definitive cure remains fraught with challenges. Japan once proudly bore the title of a technological powerhouse, leading the scientific community across various fields. However, as Nobel laureates from Japan often point out in their press conferences, the decline in basic research capabilities in Japan has become more pronounced in recent years. This issue became starkly apparent during the unprecedented disaster of the COVID-19 pandemic, as Japan fell significantly behind other countries in developing treatments for the coronavirus.

We have formed a team with the cooperation of many individuals involved in cutting-edge technologies, including medicine, biology, chemistry, and physics. We aim to harness the collective knowledge from across Japan to vigorously advance the development of treatments for various diseases.

Develop curative drugs by analysing phase separation

Human life activities are supported by the activities of various cells. It has been recently discovered that the human body is not only governed by biomolecules such as proteins functioning individually but also by the phase separation phenomenon, where these molecules form clusters and express their functions. While the involvement of phase separation phenomena in various diseases such as cancer, Alzheimer’s disease, and amyotrophic lateral sclerosis (ALS) is being elucidated, conventional measurement techniques are unable to accurately capture these phenomena.

Our core team is conducting research in the cutting-edge field of capturing phase separation phenomena. We aim to establish phase separation drug discovery, following antibody drugs and protein-protein interaction drug discovery.

Changing society through new work style

Throughout the COVID-19 pandemic, work styles have diversified globally. In addition to the traditional format of commuting to an office for work, the new option of remote work has emerged, making it possible to collaborate in real-time from different locations. Even now, with the COVID-19 situation somewhat under control, many companies continue to utilize remote work.

We operate a decentralized organization centered in Nara Prefecture, where our headquarters are located, and extend throughout Japan. By effectively utilizing each environment and time, we aim not only to aggregate academic technology seeds, which has been difficult until now, but also to achieve sustainable and productive growth by providing ideal working environments for each employee at different life stages.

最近の投稿

  • molmir was awarded the MU-TECH Research and Development Grant
  • molmir commenced on business development toward British life science ecosystem during the JETRO supported BioUK Launchpad
  • molmir was awarded at Deep Tech Venture of the Year 2025
  • CEO Dr. Mori will pitch at the Demo Day by Rising Biotech Challenge
  • molmir was interviewed at the Kansai Startup Night Vol.6 by kr36

最近のコメント

No comments to show.

アーカイブ

  • February 2025
  • October 2024
  • September 2024
  • May 2024
  • November 2022

カテゴリー

  • awards
  • Events
  • Fund-raise
  • grant
  • Others

© molmir official.